The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation. - Albor C; Anyiam O; Boyle LD; Makaronidis J; Tan R; Iftikhar S; Burzic A; Lajeunesse Trempe F; Stanley M; Bhatti A; Scragg J; Badawy L; et al. (Current obesity reports, 2026)